• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Digital Edition
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Digital Edition
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      Ape-directory
      AVCJ Private Equity Online Directory

      With its wide network of senior industry contacts, the directory is the most comprehensive online directory on private equity and venture capital in Asia. It is easy to navigate, enabling access to Asian private equity firms and professionals.

      Read more
      2016-china-cover
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

diagnostics-india
China's WuXi Diagnostics raises $150m

WuXi Diagnostics, a joint venture China diagnostics business set up by Hong Kong-listed pharmaceutical outsourcing giant WuXi AppTec and US-based Mayo Clinic has completed a $150 million Series B funding round.

  • Greater China
  • 25 February 2021
biju-mohandas
LeapFrog names co-head of healthcare

Asia and Africa-focused impact investor LeapFrog Investments has recruited Biju Mohandas as a partner and global co-lead for healthcare.

  • Australasia
  • 25 February 2021
vaccines-healthcare-drug-pharma
China’s Clover Biopharmaceuticals gets $230m Series C

Chengdu-based Clover Biopharmaceuticals has raised $230 million in Series C funding led by GL Ventures and Temasek Holdings. Oceanpine Capital, OrbiMed, and Delos Capital all re-upped.

  • Greater China
  • 24 February 2021
dna-molecule-genetic-gene
China's AnchorDx completes $40m Series C

AnchorDx, a China-based medical technology developer focused on DNA sequencing and diagnostics, has raised a $40 million Series C round led by OrbiMed and WuXi Huiying Investment.

  • Greater China
  • 24 February 2021
database
China’s Regor Therapeutics raises $90m Series B

Lilly Asia Ventures (LAV) has led a $90 million Series B round for Regor Therapeutics, a Chinese drug developer specializing in bioinformatics.

  • Greater China
  • 22 February 2021
dna-genetics
China cancer screening business gains on Hong Kong debut

New Horizon Health, a China-based and venture capital-backed cancer early screening company, rose 215% on its trading debut following a HK$2 billion ($258 million) Hong Kong IPO.

  • Greater China
  • 19 February 2021
dental-service
China's CITIC sells US dental business

CITIC Capital Partners has exited US-based dental business DDS Lab – the private equity firm’s first acquisition in the US as a lead investor – to RoundTable Healthcare Partners for an undisclosed sum.

  • Greater China
  • 19 February 2021
virus-pharma-drugs
Chinese virotherapy specialist Binhui Biotech raises $93m

Wuhan-based Binhui Biotech has raised RMB600 million ($93 million) in Series C funding led by Shenzhen-based Share Capital. Other investors include CICC Capital, Vertex Ventures China and Qianhai FOF under Shenzhen Capital Group.

  • Greater China
  • 18 February 2021
hospital-surgery-nurse
Deal focus: CPE backs MicroPort's medical devices agenda

CPE has backed a string of spinouts from Chinese medical device manufacturer MicroPort Medical. MicroPort CardioFlow Medtech’s Hong Kong IPO represents its first liquidity event

  • Greater China
  • 11 February 2021
stocks-equities-board
China's Cloopen, Adagene complete strong US IPOs

Cloud services provider Cloopen and biotech developer Adagene, both backed by Sequoia Capital China, have raised a combined $460 million in their US IPOs.

  • Central Asia
  • 11 February 2021
hospital-operation-surgeon-2
New Frontier to privatize US-listed China hospital business

The New Frontier Group-led consortium that acquired Chinese hospital operator United Family Healthcare (UFH) through a special purpose acquisition company (SPAC) in 2019 is now looking to take the US-listed business private at a valuation of around $1.6...

  • Greater China
  • 11 February 2021
healthcare-checkup-doctor-blood-pressure-medical
Sequoia, Tencent lead Series E for China’s Miaoshou Doctor

Beijing Yuanxin Technology, operator of China-based online healthcare services platform Miaoshou Doctor, has raised RMB3 billion ($466 million) in Series E funding led by Sequoia Capital China and Tencent Holdings.

  • Greater China
  • 10 February 2021
adult-care-elderly-aged
MBK targets $639m acquisition of Japan aged care business

MBK Partners has joined the list of private equity firms pursuing deals in Japan’s aged care and healthcare space, having launched a tender offer for Tsukui Holdings Corporation at a valuation of JPY66.9 billion ($639 million).

  • North Asia
  • 09 February 2021
medicine-pills-drug-healthcare2
Advent buys majority stake in India's ZCL, MSPEA exits

Advent International has agreed to acquire Indian pharmaceuticals supplier ZCL Chemicals, setting up a minority exit for Morgan Stanley Private Equity Asia (MSPEA).

  • South Asia
  • 09 February 2021
scientist-laboratory-microscope
Indigenous New Zealand LP backs pathology business

Te Puia Tapapa (TPT), a PE investor serving New Zealand indigenous groups, has backed a pathology business owned by New Zealand Superannuation Fund (NZ Super) and Ontario Teachers’ Pension Plan (OTPP).

  • Australasia
  • 05 February 2021
Tablet device in hospital
Carlyle, Brighton Park invest $200m in India's Indegene

The Carlyle Group and US GP Brighton Park Capital have committed a combined $200 million to Indegene, an Indian technology provider for the healthcare and life sciences industries.

  • South Asia
  • 04 February 2021
dna-genetics
Tencent leads Series C for China gene sequencing player

Guangzhou-based precision diagnosis and gene sequencing company Vision Medicals has raised RMB200 million ($31 million) in Series C funding led by Tencent Holdings.

  • Greater China
  • 04 February 2021
dental-service
Temasek impact arm leads Series B for Vietnam dental player

ABC World Asia, the impact investment arm of Temasek Holdings, has led a $24 million Series B found for Kim Dental, a Vietnam-based dental clinic operator. Existing backer Aura Private Equity also participated.

  • Southeast Asia
  • 04 February 2021
drug-pill-pharma-healthcare
Lilly Asia Ventures raises $1.35b for healthcare funds

Lilly Asia Ventures (LAV) has raised $1.35 billion for its latest healthcare fund, having introduced a $450 million opportunity vehicle that sits alongside a core pool of $900 million.

  • Greater China
  • 03 February 2021
dental-service
CLSA partially exits Japan medical IT provider

CLSA Capital Partners (CLSA CP) has partially exited its position in NHOSA Corporation, a Japanese IT provider for dental clinics and medical institutions.

  • North Asia
  • 01 February 2021
biotech-lab-scientist
General Atlantic backs Indonesia biotech developer

General Atlantic has invested $55 million in Kalbe Genexine Biologics, an Indonesia-based drug developer focusing on Southeast Asia.

  • Southeast Asia
  • 27 January 2021
biotech-healthcare-life-science-drug
Fund focus: LPs flock to Lake Bleu’s late show

Lake Bleu Capital leveraged a lift in Chinese healthcare sentiment to raise $560 million for a fund that will target late-stage healthcare investments

  • Greater China
  • 27 January 2021
avcj-awards-2020-operational-value-ben-hawter
AVCJ Awards 2020: Operational Value Add: Nexus Day Hospitals

Having formed Australia-based Nexus Day Hospitals by merging two smaller operators, Mercury Capital led a wholesale expansion and professionalization of the business

  • Australasia
  • 27 January 2021
rmb-funds
Qiming raises $441m for its sixth renminbi fund

Qiming Venture Partners has closed its sixth renminbi-denominate vehicle at RMB2.85 billion ($441 million), taking the firm's total assets under management to $5.9 billion.

  • Greater China
  • 26 January 2021
1 2 3

Most read

final-assembly-workshop
China EV battery maker raises $542m Series A
india-construction
Tiger leads $100m Series C for India's Infra.Market
cpu-semiconductor
VCs flock to Chinese chip designer Moore Threads
logistics-truck-aerial
FountainVest buys China logistics business
bakery-bread
Everstone exits India bakery business
  • About AVCJ
  • Advertise
  • Contacts
  • About Acuris
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013